DEA Issues Rule on Placement of Clonazolam, Diclazepam, Etizolam, Flualprazolam & Flubromazolam in Schedule I of the Controlled Substances Act
July 25, 2025
July 25, 2025
WASHINGTON, July 25 (TNSFR) -- The U.S. Department of Justice Drug Enforcement Administration has issued a rule (Docket No. DEA-989) entitled "Schedules of Controlled Substances: Placement of Clonazolam, Diclazepam, Etizolam, Flualprazolam and Flubromazolam in Schedule I of the Controlled Substances Act."
This rule proposes to permanently place clonazolam, diclazepam, etizolam, flualprazolam and flubromazolam, along with their salts, isomers and salts of isomers, in schedu . . .
This rule proposes to permanently place clonazolam, diclazepam, etizolam, flualprazolam and flubromazolam, along with their salts, isomers and salts of isomers, in schedu . . .